Evidence map›Paper›PMID 28973878›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.

Masahide Sakabe, Jieqing Fan, Yoshinobu Odaka, Ning Liu, Aishlin Hassan, Xin Duan, Paige Stump, Luke Byerly, Megan Donaldson, Jiukuan Hao and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it, 216 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Masahide SakabeDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Jieqing FanVisual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Yoshinobu OdakaVisual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Ning LiuDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Aishlin HassanDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Xin DuanDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Paige StumpDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Luke ByerlyDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Megan DonaldsonDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Jiukuan HaoDivision of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267.
Marcus FruttigerUCL Institute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom.
Qing Richard LuDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Yi ZhengDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Richard A LangVisual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229.
Mei XinDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229; Mei.Xin@cchmc.org.
Pediatrics and Genetics · USUniversity of Cincinnati Medical Center · USCincinnati Children's Hospital Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity College London · GBUniversity of Cincinnati · US

Funding

Molecular Mechanisms of Oligodendrocyte Differentiation and MyelinationR01NS072427 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2010 to 2018
$3.6M
Chromatin remodeling control of myelination and remyelinationR01NS075243 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2012 to 2018
$2.6M
Regulation of vascular development in the eye by an opsin 5-dependent clockR01EY027077 · NEI · CINCINNATI CHILDRENS HOSP MED CTR · PI LANG, RICHARD A., RAO, SUJATA · 2016 to 2020
$2.4M
Hippo Signaling in Heart Development and RepairR01HL132211 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI XIN, MEI · 2016 to 2020
$1.9M
Targeting the Hippo signaling at the Blood-brain barrier for therapy of ischemic strokeR01NS105787 · NINDS · UNIVERSITY OF HOUSTON · PI HAO, JIUKUAN · 2018 to 2023
$1.7M
Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesisR37NS096359 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI LU, QING R · 2016 to 2018
$1.6M
Application of Brain-Targeted Anti-inflammatory RNA Nanoparticle for Ischemic Stroke TherapyR21NS093493 · NINDS · UNIVERSITY OF CINCINNATI · PI HAO, JIUKUAN · 2015 to 2016
$448k
NEI NIH HHS R01 EY027077NHLBI NIH HHS R01 HL132211NINDS NIH HHS R01 NS072427NINDS NIH HHS R01 NS075243NINDS NIH HHS R01 NS105787NINDS NIH HHS R21 NS093493NINDS NIH HHS R37 NS096359
6 · The paper itself

Abstract

Angiogenesis and vascular remodeling are essential for the establishment of vascular networks during organogenesis. Here we show that the Hippo signaling pathway effectors YAP and TAZ are required, in a gene dosage-dependent manner, for the proliferation and migration of vascular endothelial cells (ECs) during retinal angiogenesis. Intriguingly, nuclear translocation of YAP and TAZ induced by

Indexed as

Cell MovementNeovascularization, PhysiologicAcyltransferasesAdaptor Proteins, Signal TransducingAnimalscdc42 GTP-Binding ProteinCell Cycle ProteinsCell ProliferationEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsMiceMice, KnockoutPhosphoproteinsSignal TransductionTranscription FactorsAcyltransferasesAdaptor Proteins, Signal Transducingcdc42 GTP-Binding ProteinCell Cycle ProteinsPhosphoproteinsTAFAZZIN protein, humantafazzin protein, mouseTranscription FactorsYAP1 protein, humanYap1 protein, mouseYAP-Signaling ProteinsangiogenesisCDC42cell migrationHippo signaling

Identifiers

PMID28973878
PMCPMC5642684
OpenAlexW2763891537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.